A novel risk score helps identify interstitial lung disease in patients with systemic sclerosis Presented ByDr Cosimo Bruni, University of Zürich, Switzerla ConferenceACR 2022 1 December, 2022 12:27
Nintedanib reduces lung function decline in systemic sclerosis-associated ILD Presented ByProf. Oliver Distler, University Hospital Zurich, Switzerland TrialSENSCIS ConferenceATS 2019 23 July, 2019 23:49